BSE Live
Feb 06, 16:01Prev. Close
140.00
Open Price
140.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 06, 15:57Prev. Close
140.25
Open Price
140.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
139.16 (3847)
| Balance Sheet of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 26.21 | 25.09 | 25.09 | 24.69 | 23.67 | |
| Total Share Capital | 26.21 | 25.09 | 25.09 | 24.69 | 23.67 | |
| Reserves and Surplus | -44.84 | 270.03 | 159.63 | 133.47 | 6.23 | |
| Total Reserves and Surplus | -44.84 | 270.03 | 159.63 | 133.47 | 6.23 | |
| Total Shareholders Funds | -18.64 | 296.24 | 184.72 | 158.16 | 29.90 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 6.38 | 1.09 | 1.64 | 2.18 | 2.73 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 39.24 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 10.23 | 6.11 | 6.34 | 4.18 | 3.30 | |
| Total Non-Current Liabilities | 55.85 | 7.20 | 7.98 | 6.36 | 6.02 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 61.42 | 0.00 | 0.10 | 0.41 | 52.48 | |
| Trade Payables | 158.84 | 82.92 | 102.48 | 94.45 | 58.15 | |
| Other Current Liabilities | 9.78 | 7.66 | 9.42 | 9.81 | 12.09 | |
| Short Term Provisions | 5.31 | 4.46 | 4.10 | 3.35 | 2.12 | |
| Total Current Liabilities | 235.36 | 95.04 | 116.11 | 108.03 | 124.84 | |
| Total Capital And Liabilities | 272.56 | 398.48 | 308.81 | 272.55 | 162.66 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 102.98 | 57.18 | 51.51 | 69.16 | 69.96 | |
| Intangible Assets | 0.88 | 0.37 | 0.23 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 3.57 | 23.93 | 3.27 | 1.47 | 0.87 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 135.93 | 81.68 | 55.00 | 70.63 | 70.83 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 24.04 | |
| Other Non-Current Assets | 69.44 | 59.41 | 78.58 | 43.64 | 1.20 | |
| Total Non-Current Assets | 205.38 | 141.09 | 133.59 | 114.27 | 96.07 | |
| CURRENT ASSETS | ||||||
| Current Investments | 8.49 | 210.58 | 107.57 | 9.65 | 0.00 | |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Receivables | 16.05 | 10.17 | 17.56 | 38.90 | 9.16 | |
| Cash And Cash Equivalents | 0.46 | 0.68 | 1.32 | 70.31 | 12.75 | |
| Short Term Loans And Advances | 0.77 | 0.55 | 0.58 | 1.41 | 44.09 | |
| OtherCurrentAssets | 41.42 | 35.41 | 48.19 | 38.01 | 0.59 | |
| Total Current Assets | 67.19 | 257.38 | 175.22 | 158.28 | 66.59 | |
| Total Assets | 272.56 | 398.48 | 308.81 | 272.55 | 162.66 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 95.62 | 109.02 | 123.44 | 78.69 | 11.78 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 5.31 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 8.51 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 227.67 | 194.25 | 159.33 | 163.45 | 110.46 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 7.19 | 135.72 | 40.23 | 142.25 | 118.53 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | 107.57 | 9.65 | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 8.49 | 210.58 | -- | 9.55 | -- |
16.01.2026
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y